XETRA - Delayed Quote EUR

BioNxt Solutions Inc. (BXT.DE)

Compare
0.2630
-0.0100
(-3.66%)
At close: January 10 at 5:35:44 PM GMT+1

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Wolfgang Probst Co-Founder, Interim CEO & Director 116.53k -- 1981

BioNxt Solutions Inc.

1820 Fir Street
Suite 270
Vancouver, BC V6J 3B1
Canada
780 818 6422 https://www.bionxt.com
Sector: 
Healthcare

Description

BioNxt Solutions Inc. engages in R&D and manufacturing of thin-film (sublingual) and skin patch (transdermal) drug delivery for neurological and autoimmune diseases, enhancing patient compliance and bioavailability. It offers diagnostic screening tests, and new active pharmaceutical production and evaluation, including precision transdermal and oral dissolvable drug formulations; oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Corporate Governance

BioNxt Solutions Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers

H6D0.DE Haleon plc
4.4650
-3.12%
 
HIGH.DE Cantourage Group SE
4.8200
0.00%
 
ZOE.DE Zoetis Inc.
160.64
+0.59%
 
B8FK.DE Biofrontera AG
2.2700
0.00%
 
27N0.DE CANNOVUM CANNABIS AG I
0.5300
+0.95%
 
VIA.DE Viatris Inc.
11.36
-1.65%
 
APPH.DE Apontis Pharma AG
10.20
+0.99%
 
PSG.DE PharmaSGP Holding SE
26.80
+0.75%
 
2HQ.DE Tilray Brands, Inc.
1.1715
-10.26%
 
DMP.DE Dermapharm Holding SE
40.05
+0.63%